Fig. 10From: Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinomaGene mutations of different IRLPs subgroups a Top 20 genes mutation of high-risk IRLPs subgroup, b Top 20 genes mutation of low-risk IRLPs subgroup, c relationship between TTN mutation and IRLPs subgroups, d relationship between TMB and IRLPs subgroupsBack to article page